V-Set Domain-Containing T-Cell Activation Inhibitor 1
"V-Set Domain-Containing T-Cell Activation Inhibitor 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A B7 antigen subtype that inhibits the costimulation of T-cell activation, proliferation, cytokine production and development of cytotoxicity. The over expression of this protein in a variety of tumor cell types suggests its role in TUMOR IMMUNE EVASION.
| Descriptor ID |
D060907
|
| MeSH Number(s) |
D12.776.467.150.900 D12.776.543.095.900 D23.050.301.285.900 D23.529.168.900
|
| Concept/Terms |
V-Set Domain-Containing T-Cell Activation Inhibitor 1- V-Set Domain-Containing T-Cell Activation Inhibitor 1
- V Set Domain Containing T Cell Activation Inhibitor 1
- Immune Costimulatory Protein B7-H4
- Immune Costimulatory Protein B7 H4
- T-Cell Costimulatory Molecule B7x
- T Cell Costimulatory Molecule B7x
- B7H4 Immune Costimulatory Protein
|
Below are MeSH descriptors whose meaning is more general than "V-Set Domain-Containing T-Cell Activation Inhibitor 1".
Below are MeSH descriptors whose meaning is more specific than "V-Set Domain-Containing T-Cell Activation Inhibitor 1".
This graph shows the total number of publications written about "V-Set Domain-Containing T-Cell Activation Inhibitor 1" by people in this website by year, and whether "V-Set Domain-Containing T-Cell Activation Inhibitor 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 3 | 0 | 3 |
| 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "V-Set Domain-Containing T-Cell Activation Inhibitor 1" by people in Profiles.
-
B7S1, a novel candidate for anti-tumor checkpoint blockade immunotherapy. Sci China Life Sci. 2018 Sep; 61(9):1132-1134.
-
MicroRNA Expression Profiling of Pancreatic Cancer Cell Line L3.6p1 Following B7-H4 Knockdown. Cell Physiol Biochem. 2017; 44(2):494-504.
-
B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer. Hum Pathol. 2017 08; 66:79-85.
-
B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes. Clin Cancer Res. 2017 Sep 01; 23(17):5202-5209.